JNJ:NYSE
Johnson & Johnson
$271.22
arrow_upward
+0.20%(+0.54) 1D
$272.00
arrow_upward
+0.29% (+0.78)bedtimeAfter hours
Closed: Sep 25, 4:00:07 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for JNJ...
Open
$271.70
High
$272.25
Low
$269.26
Mkt. cap
653.61B
Avg. vol.
6.37M
Volume
4.09M
Dividend
1.98%
Quarterly dividend
$1.34
Ex-dividend date
Aug 25, 2026
P/E ratio
31.45
52-wk high
$281.07
52-wk low
$177.32
EPS
$8.62
Beta
0.24
Shares outstanding
2.41B
No. of employees
138K
Open
$271.70
High
$272.25
Low
$269.26
Mkt. cap
653.61B
Avg. vol.
6.37M
Volume
4.09M
Dividend
1.98%
Quarterly dividend
$1.34
Ex-dividend date
Aug 25, 2026
P/E ratio
31.45
52-wk high
$281.07
52-wk low
$177.32
EPS
$8.62
Beta
0.24
Shares outstanding
2.41B
No. of employees
138K
News stories
From web sources and news partners
Yahoo Finance
·
13 hours ago
What Does Johnson & Johnson (JNJ) New Clinical Data Mean For Its Stock?
The Motley Fool
·
19 hours ago
AbbVie vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026?
Pluang
·
1 day ago
Johnson & Johnson offers safer dividend income; AbbVie delivers faster growth but with higher risk.
Benzinga
·
1 day ago
Johnson & Johnson Clinical Trials Show Progress Across Key Therapies
About Johnson & Johnson
CEOJoaquin Duato
Employees138K
FoundedJan 1886
HeadquartersNew Brunswick, New Jersey, United States
SectorPharmaceutical industry
Websitejnj.com